Clinical Laserthermia Systems AB (publ) (STO:CLS.B)

STO:CLS.B Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.87	21.55	22.51	15.33	10.45	1.71
Short-Term Investments	-	-	-	-	0.14	29.46
Cash & Short-Term Investments	3.87	21.55	22.51	15.33	10.59	31.17
Cash Growth	-76.09%	-4.27%	46.80%	44.80%	-66.03%	162.53%
Accounts Receivable	6.34	2.6	4.59	2.64	1.5	0.64
Other Receivables	1.72	1.63	2.18	2.14	8.89	5.81
Receivables	8.06	4.23	6.77	4.78	10.4	6.45
Inventory	11.11	12.7	8.15	6.12	3.07	4.61
Prepaid Expenses	0.83	0.65	0.98	0.92	0.2	0.2
Total Current Assets	23.86	39.12	38.41	27.15	24.26	42.43
Property, Plant & Equipment	4.72	3.52	13.14	3.88	1.8	1.48
Other Intangible Assets	2.47	4.68	2.56	5.83	2.48	2.28
Long-Term Accounts Receivable	-	-	-	-	0.12	0.08
Long-Term Deferred Tax Assets	12.73	12.03	13.53	7.82	5.66	3.04
Long-Term Deferred Charges	7.82	6.62	10.93	13.06	15.18	17.31
Other Long-Term Assets	14.97	10.53	-	-	-	0.12
Total Assets	66.57	76.49	78.56	57.73	49.51	66.74

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	15.31	5.88	6.3	9.17	5.93	4.31
Accrued Expenses	3.88	2.65	4.84	3.18	3.43	1.75
Short-Term Debt	-	-	-	-	30.68	35
Current Portion of Long-Term Debt	-	-	-	-	-	0.17
Current Portion of Leases	-	-	0.22	0.23	-	-
Current Income Taxes Payable	0.07	0.1	0.07	0.18	0.45	0.31
Other Current Liabilities	2.81	1.38	1.45	1.22	1.16	3.92
Total Current Liabilities	22.07	10	12.87	13.97	41.64	45.45
Long-Term Debt	-	-	-	-	-	0.1
Long-Term Leases	-	-	0.01	0.22	-	-
Other Long-Term Liabilities	-	-	-0	-	-	-
Total Liabilities	22.07	10	12.87	14.2	41.64	45.55

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	71.98	71.98	46.58	15.43	12.05	6.09
Additional Paid-In Capital	-	9.64	39.95	9.8	66.13	339.83
Retained Earnings	-24.5	-11.9	-17.77	19.63	-67.7	-323.83
Comprehensive Income & Other	0.35	-0.05	-0.03	0.92	-1.26	-0.3
Total Common Equity	47.84	69.67	68.72	45.77	9.22	21.79
Minority Interest	-3.34	-3.19	-3.04	-2.24	-1.35	-0.61
Shareholders' Equity	44.5	66.48	65.69	43.53	7.87	21.18
Total Liabilities & Equity	66.57	76.49	78.56	57.73	49.51	66.74

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	-	-	0.22	0.45	30.68	35.27
Net Cash (Debt)	3.87	21.55	22.28	14.88	-20.09	-4.11
Net Cash Growth	-75.75%	-3.30%	49.78%	-	-	-
Net Cash Per Share	0.13	0.83	2.02	4.43	-48.17	-14.29
Filing Date Shares Outstanding	31.17	31.17	20.17	6.68	0.65	0.33
Total Common Shares Outstanding	31.17	31.17	20.17	6.68	0.65	0.33
Working Capital	1.79	29.12	25.54	13.17	-17.38	-3.03
Book Value Per Share	1.53	2.24	3.41	6.85	14.15	66.22
Tangible Book Value	45.37	64.99	66.16	39.94	6.74	19.52
Tangible Book Value Per Share	1.46	2.09	3.28	5.98	10.34	59.30
Machinery	-	-	6.67	5.04	4.25	4.21
Construction In Progress	-	-	8.36	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 13, 2026

Data Sources Report a data error